There are 2789 resources available
810P - Hormonal receptors in uterine leiomyosarcomas: How far is a primary tumor from multiple metastases?
Presenter: Élia Cipriano
Session: ePoster Display
811P - The stem cell markers expression in the primary ovarian cancer tissue
Presenter: Sneghanna Gening
Session: ePoster Display
766P - Mapping BRCA1/2 variants in ovarian cancer patients: Contribution of a BRCA2 founder effect
Presenter: Teresa Duarte
Session: ePoster Display
813P - Efficacy and safety of trastuzumab deruxtecan in HER2-expressing uterine carcinosarcoma (STATICE trial, NCCH1615): A multicenter, phase II clinical trial
Presenter: Kosei Hasegawa
Session: ePoster Display
814P - Prevalence of HER2 overexpression and amplification in uterine cervical cancer: A systematic review and a meta-analysis
Presenter: Boris Itkin
Session: ePoster Display
815TiP - ENGOT/GYN1/NCRI: ATR inhibitor in combination with olaparib in gynaecological cancers with ARID1A loss or no loss (ATARI)
Presenter: Susana Banerjee
Session: ePoster Display
773P - Prognostic value of preoperative soluble interleukin 2 receptor α as a novel immune biomarker in epithelial ovarian cancer
Presenter: Hui Li
Session: ePoster Display
774P - Anlotinib plus sintilimab in patients with recurrent advanced cervical cancer: A prospective, multicenter, single-arm, phase II clinical trial
Presenter: Qin Xu
Session: ePoster Display
775P - Tremelimumab (T) + durvalumab (D) combined with metronomic oral vinorelbine (MOV): Results of the recurrent cervical cancer (RCC) cohort of the MOVIE study
Presenter: Jean-Sebastien Frenel
Session: ePoster Display